Osteoporosis therapy may involve medication along with lifestyle change. Get answers to some of the most common questions about osteoporosis treatment. It is also advised to take Vitamin D supplements during osteoporosis medications. This will increase your bone health.
Your bone mass can be measured by a machine. It uses low levels of X-rays to determine the proportion of mineral in your bones. During this painless test, you lie on a padded table as a scanner passes over your body. In most cases, only a few bones are checked — usually in the hip and spine.
Treatment recommendations are often based on an estimate of your risk of breaking a bone. In the next 10 years using information such as the bone density test. If your risk isn’t high, treatment might not include medication. Treatment might focus instead on modifying risk factors for bone loss and falls.
Reclast (zoledronic acid) is a drug used for the treatment of osteoporosis, a condition characterized by weak, fragile bones. This prescription medication is also used for treating Paget’s disease of the bone. For preventing osteoporosis in postmenopausal women, and for treating high blood calcium levels related to cancer. People who are taking steroids are at risk for osteoporosis and may benefit from Reclast injections, too.
Reclast belongs to the bisphosphonate group of drugs, which prevent bone loss and reduce calcium released from the bones. Reclast binds to bone cells called osteoclasts, which are involved in the normal process of bone breakdown. This results in reducing the rate of bone loss and in promoting normal bone formation.
Reclast is given by a healthcare provider by injection into a vein, usually for about 15 minutes. Its dosage is based on the patient’s medical condition, kidney function, and individual response to treatment.
For patients with high blood calcium levels, intravenous fluids are usually given before the medication is injected. Patients are instructed to drink plenty of fluids during treatment to decrease prevent kidney problems.
For patients with osteoporosis, the drug is given once a year. And once every two years for the prevention of the condition.
To ensure adequate bone formation, vitamin D and calcium supplements are recommended after treatments.
Prolia (denosumab) is a prescription drug used for treating osteoporosis (a condition characterized by weak, fragile bones) in postmenopausal women. Many women are at a high risk for sustaining fractures due to weak bones after menopause. Prolia may also be given to people who have not been successfully treated using other therapies.
Prolia is a manmade antibody. It is designed to bind to a protein receptor on the surface of bone cells known as osteoclasts. These cells are responsible for bone breakdown. Prolia slows down osteoclast formation, activity, and survival, thereby reducing bone breakdown and promoting normal bone formation.
Prolia is an injectable drug administered under the skin every six months by a healthcare provider. Common side effects include back pain, muscle and joint pains, and rashes. It is important to consider that the benefits of taking treatment for osteoporosis outweigh the minor side effects of the drug.